S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Eargo Stock Price, News & Analysis (NASDAQ:EAR)

$2.59
-0.01 (-0.38%)
(As of 11/29/2023 ET)
Compare
Today's Range
$2.57
▼
$2.62
50-Day Range
$1.60
▼
$2.61
52-Week Range
$1.47
▼
$16.80
Volume
26,736 shs
Average Volume
72,494 shs
Market Capitalization
$53.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

EAR stock logo

About Eargo Stock (NASDAQ:EAR)

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

EAR Stock Price History

EAR Stock News Headlines

November 23, 2023 | bizjournals.com
Once hot to go public, life sciences companies like Eargo now look at going private
November 16, 2023 | msn.com
Eargo Black Friday & Cyber Monday Deals
November 30, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
November 16, 2023 | msn.com
Get this 6-in-1 charging cable for just $17 ahead of Black Friday
November 16, 2023 | msn.com
Eargo Hearing Aid Cost and Pricing
November 15, 2023 | msn.com
Eargo 6 Review
November 8, 2023 | morningstar.com
Eargo Inc Ordinary Shares EAR
November 1, 2023 | benzinga.com
Moore Kuehn Encourages CSTR, DOC, EAR, and SRC Investors to Contact Law Firm
November 30, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
November 1, 2023 | finance.yahoo.com
Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and Innovation
November 1, 2023 | msn.com
Best Over-the-Counter Hearing Aid for You
October 30, 2023 | markets.businessinsider.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EAR, SUM, PXD
October 30, 2023 | tmcnet.com
EAR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Eargo, Inc. Is Fair to Shareholders
October 30, 2023 | benzinga.com
Eargo Shares Are Soaring Monday: What's Driving The Action?
October 30, 2023 | msn.com
Eargo stock +50% after hearing aids maker to be taken private for $2.55/share
October 30, 2023 | investorplace.com
Why Is Eargo (EAR) Stock Up 50% Today?
October 30, 2023 | marketwatch.com
Eargo to Be Taken Private by Patient Square Capital
October 30, 2023 | marketwatch.com
Eargo Shares Surge Toward Take-Private Deal Price
October 27, 2023 | finanznachrichten.de
Eargo Inc: Eargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 Locations
October 26, 2023 | marketwatch.com
Eargo Shares Pop 16% on Deal to Sell Hearing Aids at Best Buy
October 26, 2023 | finance.yahoo.com
Eargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 Locations
October 11, 2023 | msn.com
Shop our Accessibility editor's top Prime Day deals for adaptive living
October 10, 2023 | msn.com
The best October Prime Day OTC Hearing Aid deals happening now
October 4, 2023 | businesswire.com
US Hearing Aid Market Sees Rapid Growth Fueled by Technological Advancements and Regulatory Changes - ResearchAndMarkets.com
October 2, 2023 | uk.finance.yahoo.com
Revolutionizing Access: OTC Hearing Aid Act Transforms the United States Hearing Aid Market to 2028
September 28, 2023 | tmcnet.com
US Hearing Aid Market Valued at $2.71 Billion in 2022, Expected to Reach $3.98 Billion by 2028 with Technological Advancements
August 16, 2023 | forbes.com
Eargo Hearing Aids Review: Models, Costs, Pros And Cons
See More Headlines
Receive EAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eargo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
11/30/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/28/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EAR
CUSIP
N/A
CIK
1719395
Web
eargo.com
Phone
650-351-7700
Fax
N/A
Employees
243
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($7.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-157,490,000.00
Net Margins
-263.14%
Pretax Margin
-262.90%
Return on Equity
-135.08%
Return on Assets
-96.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.22
Quick Ratio
2.97

Sales & Book Value

Annual Sales
$41.11 million
Price / Sales
1.31
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.17 per share
Price / Book
1.19

Miscellaneous

Outstanding Shares
20,762,000
Free Float
20,594,000
Market Cap
$53.77 million
Optionable
Not Optionable
Beta
1.53
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. William H. Brownie (Age 56)
    Interim CEO & COO
    Comp: $625.2k
  • Mr. Adam LaponisMr. Adam Laponis (Age 47)
    Chief Financial Officer
    Comp: $586.2k
  • Mr. Daniel Shen
    Co-Founder and Chief Clinical & Science Officer
  • Mr. Mark Thorpe (Age 55)
    Chief Accounting Officer
  • Mr. Tim Trine Ph.D.
    Chief Technology Officer
  • Ms. Christy La Pierre
    Chief Legal Officer & Secretary
  • Ms. Tricia Burchell
    Senior Vice President of People Operations

Key Competitors

View All Competitors

Insiders

View All Insider Transactions














EAR Stock Analysis - Frequently Asked Questions

How have EAR shares performed in 2023?

Eargo's stock was trading at $11.50 at the start of the year. Since then, EAR stock has decreased by 77.5% and is now trading at $2.59.
View the best growth stocks for 2023 here.

Are investors shorting Eargo?

Eargo saw a drop in short interest in November. As of November 15th, there was short interest totaling 127,200 shares, a drop of 60.3% from the October 31st total of 320,200 shares. Based on an average trading volume of 103,800 shares, the short-interest ratio is presently 1.2 days. Currently, 3.7% of the company's stock are short sold.
View Eargo's Short Interest.

When is Eargo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024.
View our EAR earnings forecast.

How were Eargo's earnings last quarter?

Eargo, Inc. (NASDAQ:EAR) announced its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.71) EPS for the quarter. The business had revenue of $8.27 million for the quarter. Eargo had a negative net margin of 263.14% and a negative trailing twelve-month return on equity of 135.08%.

When did Eargo's stock split?

Eargo shares reverse split before market open on Wednesday, January 18th 2023. The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Eargo IPO?

(EAR) raised $100 million in an initial public offering on Friday, October 16th 2020. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. J.P.Morgan and BofA Securities acted as the underwriters for the IPO and Wells Fargo Securities and William Blair were co-managers.

Who are Eargo's major shareholders?

Eargo's stock is owned by a variety of institutional and retail investors. Top institutional investors include Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Adam Laponis, Christian Gormsen, David James Wu, Geoff Pardo, Healthcare Holding BV Gilde, Mark Thorpe, Mohamad Makhzoumi, Nina Richardson and William Brownie.
View institutional ownership trends.

How do I buy shares of Eargo?

Shares of EAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:EAR) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -